Givinostat: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Givinostat. Educational only — not medical advice.
Labeled uses
DUVYZAT is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 6 years of age and older.
Source: FDA labeling via NIH DailyMed (set 1a28a3db…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.